生长因子在糖尿病足溃疡愈合中的应用进展(3)

http://www.100md.com 2010年7月1日 《中国美容医学》 2010年第7期

     [14]Dong X,Xu J,Wang W,et al.Repair effect of diabetic ulcers with recombinant human epidermal growth factor loaded by sustained-release microspheres[J].Sci China C Life Sci,2008,51(11):1039-1044.

    [15]Elias PM,Arbiser J,Brown BE,et al.Epidermal vascular endothelial growth factor production is required for permeability barrier homeostasis,dermal angiogenesis,and the development of epidermal hyperplasia: implications for the pathogenesis of psoriasis[J].Am J Pathol,2008,173(3):689-699.

    [16]Brem H,Kodra A,Golinko MS,et al.Mechanism of sustained release of vascular endothelial growth factor in accelerating experimental diabetic healing[J].J Invest Dermatol,2009,129(9):2275-2287.

    [17]Hanft JR,Pollak RA,Barbul A,et al.Phase I trial on the safety of topical rhVEGF on chronic neuropathic diabetic foot ulcers[J].J Wound Care,2008,17(1):30-32,34-37.

    [18]Jeong SH,Han SK,Kim WK.Treatment of diabetic foot ulcers using a blood bank platelet concentrate[J]. Plast Reconstr Surg,2010,125(3):944-952.

    [收稿日期]2010-05-10 [修回日期]2010-06-25

    编辑/李阳利(梁文佳 蔡 黔)

上一页 第 1 2 3 页

    百拇医药网 http://www.100md.com/html/paper/1008-6455/2010/07/67-2.htm